Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Medical Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Medical Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 105 Pages

Report ld: 5352041

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Medical Transdermal Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Medical Transdermal Patch market competitiveness, regional economic performance, and supply chain configurations.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The global Medical Transdermal Patch market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grunenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Methyl Salicylate-based Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segment by Application

Rx Channel
OTC Channel

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Medical Transdermal Patch market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Diclofenac Patch in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., OTC Channel in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Medical Transdermal Patch value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Medical Transdermal Patch Product Scope

1.2 Medical Transdermal Patch by Type

1.2.1 Global Medical Transdermal Patch Sales by Type (2020 & 2024 & 2031)

1.2.2 Methyl Salicylate-based Patch

1.2.3 Diclofenac Patch

1.2.4 Nicotine Transdermal Patch

1.2.5 Others

1.3 Medical Transdermal Patch by Application

1.3.1 Global Medical Transdermal Patch Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Rx Channel

1.3.3 OTC Channel

1.4 Global Medical Transdermal Patch Market Estimates and Forecasts (2020-2031)

1.4.1 Global Medical Transdermal Patch Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Medical Transdermal Patch Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Medical Transdermal Patch Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Medical Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Medical Transdermal Patch Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Medical Transdermal Patch Sales Market Share by Region (2020-2025)

2.2.2 Global Medical Transdermal Patch Revenue Market Share by Region (2020-2025)

2.3 Global Medical Transdermal Patch Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Medical Transdermal Patch Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Medical Transdermal Patch Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Medical Transdermal Patch Market Size and Prospective (2020-2031)

2.4.2 Europe Medical Transdermal Patch Market Size and Prospective (2020-2031)

2.4.3 China Medical Transdermal Patch Market Size and Prospective (2020-2031)

2.4.4 Japan Medical Transdermal Patch Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Medical Transdermal Patch Historic Market Review by Type (2020-2025)

3.1.1 Global Medical Transdermal Patch Sales by Type (2020-2025)

3.1.2 Global Medical Transdermal Patch Revenue by Type (2020-2025)

3.1.3 Global Medical Transdermal Patch Price by Type (2020-2025)

3.2 Global Medical Transdermal Patch Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Medical Transdermal Patch Sales Forecast by Type (2026-2031)

3.2.2 Global Medical Transdermal Patch Revenue Forecast by Type (2026-2031)

3.2.3 Global Medical Transdermal Patch Price Forecast by Type (2026-2031)

3.3 Different Types Medical Transdermal Patch Representative Players

4 Global Market Size by Application

4.1 Global Medical Transdermal Patch Historic Market Review by Application (2020-2025)

4.1.1 Global Medical Transdermal Patch Sales by Application (2020-2025)

4.1.2 Global Medical Transdermal Patch Revenue by Application (2020-2025)

4.1.3 Global Medical Transdermal Patch Price by Application (2020-2025)

4.2 Global Medical Transdermal Patch Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Medical Transdermal Patch Sales Forecast by Application (2026-2031)

4.2.2 Global Medical Transdermal Patch Revenue Forecast by Application (2026-2031)

4.2.3 Global Medical Transdermal Patch Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Medical Transdermal Patch Application

5 Competition Landscape by Players

5.1 Global Medical Transdermal Patch Sales by Players (2020-2025)

5.2 Global Top Medical Transdermal Patch Players by Revenue (2020-2025)

5.3 Global Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2024)

5.4 Global Medical Transdermal Patch Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application

5.7 Global Key Manufacturers of Medical Transdermal Patch, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Medical Transdermal Patch Sales by Company

6.1.1.1 North America Medical Transdermal Patch Sales by Company (2020-2025)

6.1.1.2 North America Medical Transdermal Patch Revenue by Company (2020-2025)

6.1.2 North America Medical Transdermal Patch Sales Breakdown by Type (2020-2025)

6.1.3 North America Medical Transdermal Patch Sales Breakdown by Application (2020-2025)

6.1.4 North America Medical Transdermal Patch Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Medical Transdermal Patch Sales by Company

6.2.1.1 Europe Medical Transdermal Patch Sales by Company (2020-2025)

6.2.1.2 Europe Medical Transdermal Patch Revenue by Company (2020-2025)

6.2.2 Europe Medical Transdermal Patch Sales Breakdown by Type (2020-2025)

6.2.3 Europe Medical Transdermal Patch Sales Breakdown by Application (2020-2025)

6.2.4 Europe Medical Transdermal Patch Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Medical Transdermal Patch Sales by Company

6.3.1.1 China Medical Transdermal Patch Sales by Company (2020-2025)

6.3.1.2 China Medical Transdermal Patch Revenue by Company (2020-2025)

6.3.2 China Medical Transdermal Patch Sales Breakdown by Type (2020-2025)

6.3.3 China Medical Transdermal Patch Sales Breakdown by Application (2020-2025)

6.3.4 China Medical Transdermal Patch Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Medical Transdermal Patch Sales by Company

6.4.1.1 Japan Medical Transdermal Patch Sales by Company (2020-2025)

6.4.1.2 Japan Medical Transdermal Patch Revenue by Company (2020-2025)

6.4.2 Japan Medical Transdermal Patch Sales Breakdown by Type (2020-2025)

6.4.3 Japan Medical Transdermal Patch Sales Breakdown by Application (2020-2025)

6.4.4 Japan Medical Transdermal Patch Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Hisamitsu Pharmaceutical

7.1.1 Hisamitsu Pharmaceutical Company Information

7.1.2 Hisamitsu Pharmaceutical Business Overview

7.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Products Offered

7.1.5 Hisamitsu Pharmaceutical Recent Development

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Company Information

7.2.2 Johnson & Johnson Business Overview

7.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Johnson & Johnson Medical Transdermal Patch Products Offered

7.2.5 Johnson & Johnson Recent Development

7.3 Novartis

7.3.1 Novartis Company Information

7.3.2 Novartis Business Overview

7.3.3 Novartis Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Novartis Medical Transdermal Patch Products Offered

7.3.5 Novartis Recent Development

7.4 UCB Pharma

7.4.1 UCB Pharma Company Information

7.4.2 UCB Pharma Business Overview

7.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.4.4 UCB Pharma Medical Transdermal Patch Products Offered

7.4.5 UCB Pharma Recent Development

7.5 Mylan

7.5.1 Mylan Company Information

7.5.2 Mylan Business Overview

7.5.3 Mylan Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Mylan Medical Transdermal Patch Products Offered

7.5.5 Mylan Recent Development

7.6 Teva Pharmaceutical

7.6.1 Teva Pharmaceutical Company Information

7.6.2 Teva Pharmaceutical Business Overview

7.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Teva Pharmaceutical Medical Transdermal Patch Products Offered

7.6.5 Teva Pharmaceutical Recent Development

7.7 Nitto Denko

7.7.1 Nitto Denko Company Information

7.7.2 Nitto Denko Business Overview

7.7.3 Nitto Denko Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Nitto Denko Medical Transdermal Patch Products Offered

7.7.5 Nitto Denko Recent Development

7.8 Grunenthal

7.8.1 Grunenthal Company Information

7.8.2 Grunenthal Business Overview

7.8.3 Grunenthal Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Grunenthal Medical Transdermal Patch Products Offered

7.8.5 Grunenthal Recent Development

7.9 IBSA Group

7.9.1 IBSA Group Company Information

7.9.2 IBSA Group Business Overview

7.9.3 IBSA Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.9.4 IBSA Group Medical Transdermal Patch Products Offered

7.9.5 IBSA Group Recent Development

7.10 GSK

7.10.1 GSK Company Information

7.10.2 GSK Business Overview

7.10.3 GSK Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.10.4 GSK Medical Transdermal Patch Products Offered

7.10.5 GSK Recent Development

7.11 Luye Pharma Group

7.11.1 Luye Pharma Group Company Information

7.11.2 Luye Pharma Group Business Overview

7.11.3 Luye Pharma Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Luye Pharma Group Medical Transdermal Patch Products Offered

7.11.5 Luye Pharma Group Recent Development

7.12 Pfizer

7.12.1 Pfizer Company Information

7.12.2 Pfizer Business Overview

7.12.3 Pfizer Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Pfizer Medical Transdermal Patch Products Offered

7.12.5 Pfizer Recent Development

7.13 Chattem

7.13.1 Chattem Company Information

7.13.2 Chattem Business Overview

7.13.3 Chattem Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Chattem Medical Transdermal Patch Products Offered

7.13.5 Chattem Recent Development

7.14 Bayer

7.14.1 Bayer Company Information

7.14.2 Bayer Business Overview

7.14.3 Bayer Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Bayer Medical Transdermal Patch Products Offered

7.14.5 Bayer Recent Development

7.15 Mundipharma

7.15.1 Mundipharma Company Information

7.15.2 Mundipharma Business Overview

7.15.3 Mundipharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.15.4 Mundipharma Medical Transdermal Patch Products Offered

7.15.5 Mundipharma Recent Development

7.16 Endo International

7.16.1 Endo International Company Information

7.16.2 Endo International Business Overview

7.16.3 Endo International Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.16.4 Endo International Medical Transdermal Patch Products Offered

7.16.5 Endo International Recent Development

7.17 Beijing Tide Pharmaceutical

7.17.1 Beijing Tide Pharmaceutical Company Information

7.17.2 Beijing Tide Pharmaceutical Business Overview

7.17.3 Beijing Tide Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

7.17.4 Beijing Tide Pharmaceutical Medical Transdermal Patch Products Offered

7.17.5 Beijing Tide Pharmaceutical Recent Development

8 Medical Transdermal Patch Manufacturing Cost Analysis

8.1 Medical Transdermal Patch Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Medical Transdermal Patch

8.4 Medical Transdermal Patch Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Medical Transdermal Patch Distributors List

9.3 Medical Transdermal Patch Customers

10 Medical Transdermal Patch Market Dynamics

10.1 Medical Transdermal Patch Industry Trends

10.2 Medical Transdermal Patch Market Drivers

10.3 Medical Transdermal Patch Market Challenges

10.4 Medical Transdermal Patch Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Medical Transdermal Patch Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Medical Transdermal Patch Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Medical Transdermal Patch Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Medical Transdermal Patch Sales (K Units) by Region (2020-2025)

Table 5. Global Medical Transdermal Patch Sales Market Share by Region (2020-2025)

Table 6. Global Medical Transdermal Patch Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Medical Transdermal Patch Revenue Share by Region (2020-2025)

Table 8. Global Medical Transdermal Patch Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Medical Transdermal Patch Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Medical Transdermal Patch Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Medical Transdermal Patch Revenue Share Forecast by Region (2026-2031)

Table 12. Global Medical Transdermal Patch Sales by Type (K Units) & (2020-2025)

Table 13. Global Medical Transdermal Patch Sales Share by Type (2020-2025)

Table 14. Global Medical Transdermal Patch Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Medical Transdermal Patch Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Medical Transdermal Patch Sales by Type (K Units) & (2026-2031)

Table 17. Global Medical Transdermal Patch Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Medical Transdermal Patch Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Medical Transdermal Patch Sales by Application (K Units) & (2020-2025)

Table 21. Global Medical Transdermal Patch Sales Share by Application (2020-2025)

Table 22. Global Medical Transdermal Patch Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Medical Transdermal Patch Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Medical Transdermal Patch Sales by Application (K Units) & (2026-2031)

Table 25. Global Medical Transdermal Patch Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Medical Transdermal Patch Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Medical Transdermal Patch Application

Table 28. Global Medical Transdermal Patch Sales by Company (K Units) & (2020-2025)

Table 29. Global Medical Transdermal Patch Sales Share by Company (2020-2025)

Table 30. Global Medical Transdermal Patch Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Medical Transdermal Patch Revenue Share by Company (2020-2025)

Table 32. Global Medical Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2024)

Table 33. Global Market Medical Transdermal Patch Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application

Table 36. Global Key Manufacturers of Medical Transdermal Patch, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Medical Transdermal Patch Sales by Company (2020-2025) & (K Units)

Table 39. North America Medical Transdermal Patch Sales Market Share by Company (2020-2025)

Table 40. North America Medical Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Medical Transdermal Patch Revenue Market Share by Company (2020-2025)

Table 42. North America Medical Transdermal Patch Sales by Type (2020-2025) & (K Units)

Table 43. North America Medical Transdermal Patch Sales Market Share by Type (2020-2025)

Table 44. North America Medical Transdermal Patch Sales by Application (2020-2025) & (K Units)

Table 45. North America Medical Transdermal Patch Sales Market Share by Application (2020-2025)

Table 46. Europe Medical Transdermal Patch Sales by Company (2020-2025) & (K Units)

Table 47. Europe Medical Transdermal Patch Sales Market Share by Company (2020-2025)

Table 48. Europe Medical Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Medical Transdermal Patch Revenue Market Share by Company (2020-2025)

Table 50. Europe Medical Transdermal Patch Sales by Type (2020-2025) & (K Units)

Table 51. Europe Medical Transdermal Patch Sales Market Share by Type (2020-2025)

Table 52. Europe Medical Transdermal Patch Sales by Application (2020-2025) & (K Units)

Table 53. Europe Medical Transdermal Patch Sales Market Share by Application (2020-2025)

Table 54. China Medical Transdermal Patch Sales by Company (2020-2025) & (K Units)

Table 55. China Medical Transdermal Patch Sales Market Share by Company (2020-2025)

Table 56. China Medical Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Medical Transdermal Patch Revenue Market Share by Company (2020-2025)

Table 58. China Medical Transdermal Patch Sales by Type (2020-2025) & (K Units)

Table 59. China Medical Transdermal Patch Sales Market Share by Type (2020-2025)

Table 60. China Medical Transdermal Patch Sales by Application (2020-2025) & (K Units)

Table 61. China Medical Transdermal Patch Sales Market Share by Application (2020-2025)

Table 62. Japan Medical Transdermal Patch Sales by Company (2020-2025) & (K Units)

Table 63. Japan Medical Transdermal Patch Sales Market Share by Company (2020-2025)

Table 64. Japan Medical Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Medical Transdermal Patch Revenue Market Share by Company (2020-2025)

Table 66. Japan Medical Transdermal Patch Sales by Type (2020-2025) & (K Units)

Table 67. Japan Medical Transdermal Patch Sales Market Share by Type (2020-2025)

Table 68. Japan Medical Transdermal Patch Sales by Application (2020-2025) & (K Units)

Table 69. Japan Medical Transdermal Patch Sales Market Share by Application (2020-2025)

Table 70. Hisamitsu Pharmaceutical Company Information

Table 71. Hisamitsu Pharmaceutical Description and Business Overview

Table 72. Hisamitsu Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Hisamitsu Pharmaceutical Medical Transdermal Patch Product

Table 74. Hisamitsu Pharmaceutical Recent Development

Table 75. Johnson & Johnson Company Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Johnson & Johnson Medical Transdermal Patch Product

Table 79. Johnson & Johnson Recent Development

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Novartis Medical Transdermal Patch Product

Table 84. Novartis Recent Development

Table 85. UCB Pharma Company Information

Table 86. UCB Pharma Description and Business Overview

Table 87. UCB Pharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. UCB Pharma Medical Transdermal Patch Product

Table 89. UCB Pharma Recent Development

Table 90. Mylan Company Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Medical Transdermal Patch Product

Table 94. Mylan Recent Development

Table 95. Teva Pharmaceutical Company Information

Table 96. Teva Pharmaceutical Description and Business Overview

Table 97. Teva Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Teva Pharmaceutical Medical Transdermal Patch Product

Table 99. Teva Pharmaceutical Recent Development

Table 100. Nitto Denko Company Information

Table 101. Nitto Denko Description and Business Overview

Table 102. Nitto Denko Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Nitto Denko Medical Transdermal Patch Product

Table 104. Nitto Denko Recent Development

Table 105. Grunenthal Company Information

Table 106. Grunenthal Description and Business Overview

Table 107. Grunenthal Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Grunenthal Medical Transdermal Patch Product

Table 109. Grunenthal Recent Development

Table 110. IBSA Group Company Information

Table 111. IBSA Group Description and Business Overview

Table 112. IBSA Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. IBSA Group Medical Transdermal Patch Product

Table 114. IBSA Group Recent Development

Table 115. GSK Company Information

Table 116. GSK Description and Business Overview

Table 117. GSK Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. GSK Medical Transdermal Patch Product

Table 119. GSK Recent Development

Table 120. Luye Pharma Group Company Information

Table 121. Luye Pharma Group Description and Business Overview

Table 122. Luye Pharma Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Luye Pharma Group Medical Transdermal Patch Product

Table 124. Luye Pharma Group Recent Development

Table 125. Pfizer Company Information

Table 126. Pfizer Description and Business Overview

Table 127. Pfizer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Pfizer Medical Transdermal Patch Product

Table 129. Pfizer Recent Development

Table 130. Chattem Company Information

Table 131. Chattem Description and Business Overview

Table 132. Chattem Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Chattem Medical Transdermal Patch Product

Table 134. Chattem Recent Development

Table 135. Bayer Company Information

Table 136. Bayer Description and Business Overview

Table 137. Bayer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Bayer Medical Transdermal Patch Product

Table 139. Bayer Recent Development

Table 140. Mundipharma Company Information

Table 141. Mundipharma Description and Business Overview

Table 142. Mundipharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Mundipharma Medical Transdermal Patch Product

Table 144. Mundipharma Recent Development

Table 145. Endo International Company Information

Table 146. Endo International Description and Business Overview

Table 147. Endo International Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Endo International Medical Transdermal Patch Product

Table 149. Endo International Recent Development

Table 150. Beijing Tide Pharmaceutical Company Information

Table 151. Beijing Tide Pharmaceutical Description and Business Overview

Table 152. Beijing Tide Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Beijing Tide Pharmaceutical Medical Transdermal Patch Product

Table 154. Beijing Tide Pharmaceutical Recent Development

Table 155. Production Base and Market Concentration Rate of Raw Material

Table 156. Key Suppliers of Raw Materials

Table 157. Medical Transdermal Patch Distributors List

Table 158. Medical Transdermal Patch Customers List

Table 159. Medical Transdermal Patch Market Trends

Table 160. Medical Transdermal Patch Market Drivers

Table 161. Medical Transdermal Patch Market Challenges

Table 162. Medical Transdermal Patch Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Transdermal Patch Product Picture

Figure 2. Global Medical Transdermal Patch Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Medical Transdermal Patch Sales Market Share by Type in 2024 & 2031

Figure 4. Methyl Salicylate-based Patch Product Picture

Figure 5. Diclofenac Patch Product Picture

Figure 6. Nicotine Transdermal Patch Product Picture

Figure 7. Others Product Picture

Figure 8. Global Medical Transdermal Patch Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 9. Global Medical Transdermal Patch Sales Market Share by Application in 2024 & 2031

Figure 10. Rx Channel Examples

Figure 11. OTC Channel Examples

Figure 12. Global Medical Transdermal Patch Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Medical Transdermal Patch Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Medical Transdermal Patch Sales (K Units) Growth Rate (2020-2031)

Figure 15. Global Medical Transdermal Patch Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 16. Medical Transdermal Patch Report Years Considered

Figure 17. Global Market Medical Transdermal Patch Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Medical Transdermal Patch Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Medical Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Medical Transdermal Patch Sales (K Units) Growth Rate (2020-2031)

Figure 21. Europe Medical Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Medical Transdermal Patch Sales (K Units) Growth Rate (2020-2031)

Figure 23. China Medical Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Medical Transdermal Patch Sales (K Units) Growth Rate (2020-2031)

Figure 25. Japan Medical Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Japan Medical Transdermal Patch Sales (K Units) Growth Rate (2020-2031)

Figure 27. Global Medical Transdermal Patch Revenue Share by Type (2020-2025)

Figure 28. Global Medical Transdermal Patch Sales Share by Type (2026-2031)

Figure 29. Global Medical Transdermal Patch Revenue Share by Type (2026-2031)

Figure 30. Global Medical Transdermal Patch Revenue Share by Application (2020-2025)

Figure 31. Global Medical Transdermal Patch Revenue Growth Rate by Application in 2020 & 2024

Figure 32. Global Medical Transdermal Patch Sales Share by Application (2026-2031)

Figure 33. Global Medical Transdermal Patch Revenue Share by Application (2026-2031)

Figure 34. Global Medical Transdermal Patch Sales Share by Company (2024)

Figure 35. Global Medical Transdermal Patch Revenue Share by Company (2024)

Figure 36. Global 5 Largest Medical Transdermal Patch Players Market Share by Revenue in Medical Transdermal Patch: 2020 & 2024

Figure 37. Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Manufacturing Cost Structure of Medical Transdermal Patch

Figure 39. Manufacturing Process Analysis of Medical Transdermal Patch

Figure 40. Medical Transdermal Patch Industrial Chain

Figure 41. Channels of Distribution (Direct Vs Distribution)

Figure 42. Distributors Profiles

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Medical Transdermal Patch market? zhanKai

The top companies in the global Medical Transdermal Patch market are Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis.

Related Reports

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 151
USD 3950.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2026
The global Medical Transdermal Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 130
USD 2900.00
(Single User License)
Global Medical Transdermal Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 173
USD 4900.00
(Single User License)
Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 144
USD 3950.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2025
The global market for Medical Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 102
USD 2900.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2024
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
Published Date: 2024-02-07
Pages: 105
USD 2900.00
(Single User License)

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 151
USD 3950.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2026
The global Medical Transdermal Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 130
USD 2900.00 (Single User License)
Global Medical Transdermal Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 173
USD 4900.00 (Single User License)
Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 144
USD 3950.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2025
The global market for Medical Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 102
USD 2900.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2024
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
Published: 2024-02-07
Pages: 105
USD 2900.00 (Single User License)